UMB Dataset
Approaches to Potentiated Neuroprotective Treatment in the Rodent Model of Ischemic Optic Neuropathy
UID: 206
- Description
- Nonarthritic anterior ischemic optic neuropathy (NAION) commonly causes sudden optic nerve (ON)-related vision loss. The rodent NAION model (rAION) closely resembles NAION in presentation and physiological responses. Researchers hypothesized that blocking pro-inflammatory prostaglandin (PGE2) production by inhibiting monoacylglycerol lipase or cyclooxygenase activity and co-administering PGJ2 would potentiate RGC survival following ischemic neuropathy. This study identified early rAION-associated optic nerve head (ONH) inflammatory gene expression responses and the anti-inflammatory prostaglandin PGJ2’s effects on those responses. Deep sequencing was performed on vehicle- and PGJ2-treated ONHs 3d post-rAION induction. Results were compared against responses from a retinal ischemia model. Animals were treated with PGJ2 and MAGL inhibitor KML29, or PGJ2 + COX inhibitor meloxicam. RGC survival was quantified by stereology.
- Timeframe
- 2021
Sprague Dawley
Associated Publications
Data Type
Equipment Used
Software Used
Study Type
Dataset Format(s)
Microsoft Excel
Dataset Size
3.8MB
Access
- Restrictions
-
Unrestricted access
- Instructions
- Data available via article and Figshare
planoconver contact lens
rat fundus contact lens
warming pads
Stereo Investigator 10
Interventional
- Grant Support
-
RO1EY015304/National Eye InstituteR21EY028690/National Eye Institute